In a phase 3 trial published Oct. 24, 2026, in Aesthetic Surgery Journal, 60.0% of adults treated with trenibotulinumtoxinE met a strict frown-line goal at day 7 vs. 0.6% with placebo; the…
A UK study published Oct. 30, 2026, in the British Journal of Dermatology compared 320,220 people with psoriasis with 1,706,424 matched people and found links with conditions across the body, including liver…
In a study of 77 people with mucous membrane pemphigoid affecting several body sites, published Oct. 28, 2026, in JAMA Dermatology, 45% reached complete remission at every site at once, after a…
A meta-analysis of thirteen studies with more than 500,000 people, published Oct. 28, 2026, in Dermatologic Surgery, found that Mohs surgery for melanoma was linked to similar or better long-term survival than…
A study of eighty-three patients published Oct. 26, 2026, in Dermatologic Surgery found that local surgical removal of hidradenitis suppurativa lesions lowered average pain from 6.9 to 0.9 on a visual pain…
Joint guidelines from the American Academy of Dermatology and the Hidradenitis Suppurativa Foundation, published Oct. 20, 2026, make 37 recommendations, with strong support for four biologic drugs and for checking pain at…
In a small phase 1 study published Oct. 30, 2026, in the Journal of the American Academy of Dermatology, low-dose cemiplimab injected into early squamous cell skin cancers left no cancer under…
